Dr Caitlin Rice (2024)

Fiona Stanley Hospital, Western Australia

Current AHCDO Research Fellow

Dr Radha Ramanan (2022-2023)

Alfred Hospital, Victoria

Publication

Ramanan R, Evans N, Kaplan Z, McFadyen JD, Tran HA. Mutational landscape, inhibitor development, and health-care burden in non-severe haemophilia a: A single-centre Australian experience. Haemophilia. 2024

Ramanan R, Parikh S, Aung LL, McFadyen JD, Tran HA. Intraindividual bleeding outcomes in patients with hemophilia A on emicizumab prophylaxis in Australia. Blood Vessels, Thrombosis & Hemostasis. 2024;1:100005

Conference Presentations

Phenotypic characterisation of congenital fibrinogen disorders in Australia

Ramanan R, P’Ng, S, Goruppi M, Curnow J, Hooi A, Perkins AC, McFadyen JD, Tran HA

Jan 2024          Poster presentation for ISTH 2024

Evaluation of real-world bleeding outcomes in patients with haemophilia A (HA) with or without inhibitors on emicizumab prophylaxis in Australia

Ramanan R, Parikh S, McFadyen J, Tran H

June 2023      Poster presentation for ISTH 2023 Congress

July 2022        Poster presentation for Monash University Translational Symposium

Sept 2022       Poster presentation for Blood 2022

Evaluation of real-world peri-operative outcomes in patients with haemophilia A (HA) with or without inhibitors on emicizumab prophylaxis in Australia

Ramanan R, P’Ng S, Goruppi M, McFadyen JD, Tran HA

Jan 2024         Poster presentation for ISTH 2024

Sept 2022       Poster presentation for Blood 2022

Phenotypic characterisation of congenital fibrinogen disorders: a single centre experience

Ramanan R, Parikh S, McFadyen J, Tran H

Sept 2022        Poster presentation for Blood 2022

Dr Carly George (2020-2021)

Publications

George C, Parikh S, Carter T, Morris A, Cramey C, McElroy K, Tran H. Haemophilia joint health score (HJHS) usage, patterns and outcome data in patients with haemophilia A and haemophilia B in Australia: A descriptive study using the Australian Bleeding Disorders Registry (ABDR). Haemophilia. 2023;29:1135-1141

George C, Parikh S, Carter T, McCosker J, Carlino S, Tran H. Evaluation of treatment and outcome for patients with haemophilia A and haemophilia B on extended half-life (EHL) factor products: A 12-month data analysis. Haemophilia. 2023;29:1283-1290

Conference Presentations

Parikh S, George C, McRae S, Carter T, McCosker J, Carlino S, Tran H. Comprehensive evaluation of treatment and outcome for patients with haemophilia A and haemophilia B on extended half life (EHL) products: A 12 month data analysis. Blood. 2021

Dr Yvonne Brennan (2019)

Publications

Brennan Y, Parikh S, McRae S, Tran H. The Australian experience with switching to extended half-life factor VIII and IX concentrates: On behalf of the Australian Haemophilia Centre Directors' Organisation. Haemophilia. 2020;26:529-535

Oral Presentations

19th Australian Conference on haemophilia, VWD & rare bleeding disorders. “The basics about blood clotting and how this interacts with factor replacement/novel therapies.” Sydney, Oct 2019.

AHCDO Education Day. “Results of the national extended half-life factor implementation audit.” Sydney, Oct 2019.​

Poster Presentations

Extended half-life clotting factor use in Australia. Brennan Y, Parikh S, McRae S, Tran H., Blood, Perth, 2019.

Investigation of a prolonged APTT reveals a rare finding. Brennan Y, Kershaw G, Cai N, Curtin J., Blood, Perth, 2019 and THANZ Workshop, Perth, 2019.

SMS bleed capture project. Brennan Y, Hooi A, Shoemark R, Curtin J., Blood, Perth, 2019​

Dr Sally Campbell (2018)

Publications

Campbell S, Mason J, Prasad R, Ambrose H, Hunt S, Tran H. Acquired haemophilia and haemostatic control with recombinant porcine factor VIII: Case series. Intern Med J. 2021;51:215-219

Mezhov V, Campbell S, Powell A, Tran H. Pseudotumours in haemophilia: Non-adherence, under-reporting bleeds or bad luck? Intern Med J. 2019;49:1171-1173

Campbell S, Parikh S, Tran HA. Complication rates of central venous access devices in patients with inherited bleeding disorders in Australia. Br J Haematol. 2019;186:e86-e88

Poster Presentations

Haemostatic therapy for the insertion of central venous access devices in severe haemophilia A and B - Melbourne paediatric protocol. Campbell S, Ekert JE, Furmedge JF, Barnes C., ISTH, Melbourne, 2019

Genetic landscape of haemophilia A and B in Australia. Campbell S, Parikh S, Tran H., ISTH, Melbourne, 2019

Dr Jane Mason (2017)

Publications

Mason JA, Parikh S, Tran H, Rowell J, McRae S. Australian multicentre study of current real-world prophylaxis practice in severe and moderate haemophilia A and B. Haemophilia. 2018;24:253-260

Mason JA, Aung HT, Nandini A, Woods RG, Fairbairn DJ, Rowell JA, Young D, Susman RD, Brown SA, Hyland VJ, Robertson JD. Demonstration of a novel Xp22.2 microdeletion as the cause of familial extreme skewing of X-inactivation utilizing case-parent trio SNP microarray analysis. Mol Genet Genomic Med. 2018;6:357-369

Anderson JA, Mason JA, Halliday B. Clinical outcomes and patient satisfaction following total hip and knee arthroplasty in patients with inherited bleeding disorders: A 20-year single-surgeon cohort. Haemophilia. 2018;24:786-791

Poster Presentations

In pursuit of pristine joints: where are we with prophylaxis? Presentation. Mason JA, Parikh S. October 2017. 18th Australian & New Zealand Conference on Haemophilia & Rare Bleeding Disorders.

Impact of the SIPPET study on management of Australian PUPs. International Society of Thrombosis and Haemostasis Congress. July 2019, Melbourne.